ITCI Intra-Cellular Therapies
- 69.970
- +1.170+1.70%
Intra-Cellular Therapies所有資訊
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-董事 VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股變動聲明-董事 RIGGS RORY B
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股變動聲明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股變動聲明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股變動聲明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Hineline Lawrence J.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Halstead Michael
Intra-Cellular Therapies | 4：持股變動聲明-高管 Neumann Mark
Intra-Cellular Therapies | 4：持股變動聲明-高管 Durgam Suresh K.
Intra-Cellular Therapies | 4：持股變動聲明-高管 Mates Sharon
Intra-Cellular Therapies | 4：持股變動聲明-董事 VAN NOSTRAND ROBERT L
分析
目標價預測
暫無數據
